Foghorn Therapeutics (FHTX) Analyst & Key Data

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

8

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.42

Median Target+164.03%

$11.67

Potential upside vs current price

Current Stock Price

$4.42

Median Target+164.03%

$11.67

Potential upside vs current price

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

8

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.42

Median Target+164.03%

$11.67

Potential upside vs current price

Current Stock Price

$4.42

Median Target+164.03%

$11.67

Potential upside vs current price

Foghorn Therapeutics Inc.